Large-cap U.S. stocks have been on a relentless bull run for the better part of the last two years. Despite sticky inflation, geopolitical turmoil, and historically high valuations for most major indexes, U.S. large caps have shown no signs of cooling off in 2024.

In line with this trend, Eli Lilly (NYSE: LLY), a major player in metabolic disorders, cancer, immunology, and neuroscience, has seen its shares rise nearly 60% this year.

Image source: Getty Images.

Continue reading

Source Fool.com